Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT06359249
Other study ID # V.3-06/02/2024
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date March 1, 2024
Est. completion date December 28, 2026

Study information

Verified date March 2024
Source Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Constipation is one of the most common digestive problems in today's society. In Spain, it is estimated that this condition affects between 12% and 20% of the population, being more frequent in women, contributing considerably to the quality of life, to the increase of medical visits and to high costs for the health system. The objectives of the study are to reduce the rate of constipation and laxative use in the short term with a structured rehabilitation programme consisting of abdominal massage therapy and behavioural re-education, to improve the quality of life of these patients, and to assess whether the proposed treatment is effective in the short and medium term.


Description:

Background: Constipation is one of the most common digestive problems in today's society. In Spain, it is estimated that this condition affects between 12% and 20% of the population, being more frequent in women, contributing considerably to the quality of life, to the increase of medical visits and to high costs for the health system. The objectives of the study are to reduce the rate of constipation and laxative use in the short term with a structured rehabilitation programme consisting of abdominal massage therapy and behavioural re-education, to improve the quality of life of these patients, and to assess whether the proposed treatment is effective in the short and medium term. Method: Randomised clinical trial. Participants: people with constipation in the region of L'Anoia, Catalonia. There will be 3 groups: the control group (CG), behavioural intervention group (BIG) and behavioural intervention and massage group (BIMG). Constipation will be assessed with the Bristol scale, Rome IV Criteria and the number of laxatives; and quality of life with the CVE-20 Questionnaire. Participants will be proposed from Primary Care Centres in the region of L'Anoia, Catalonia, Spain. Inclusion criteria: - Having been diagnosed with primary constipation using Rome IV Criteria(11), of more than three months' duration. - Understanding Catalan, Spanish or English. Exclusion criteria: - Having constipation secondary to neurogenic, metabolic, endocrine or postoperative diseases. - Having constipation secondary to medication for other pathologies, the medication list for which can be found in the annex. - Having any type of open abdominal and/or anal wound, such as a recent abdominal scar or anal fissure. - Meeting any absolute contraindication criteria for the use of abdominal massage therapy, such as an unstable fracture requiring absolute rest and immobilisation, pregnancy or active oncological procedures. - Suffering from some type of cognitive, psychiatric or neurological alteration that does not allow to understand the project. Discussion: Research is needed on conservative, non-pharmacological treatment to try to reduce one of the main conditions affecting public health, and thus reduce the possible illnesses associated with constipation and reduce costs to the health system.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 45
Est. completion date December 28, 2026
Est. primary completion date December 28, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - Having been diagnosed with primary constipation using Rome IV Criteria(11), of more than three months' duration. - Understanding Catalan, Spanish or English. Exclusion Criteria: - Having constipation secondary to neurogenic, metabolic, endocrine or postoperative diseases. - Having constipation secondary to medication for other pathologies, the medication list for which can be found in the annex. - Having any type of open abdominal and/or anal wound, such as a recent abdominal scar or anal fissure. - Meeting any absolute contraindication criteria for the use of abdominal massage therapy, such as an unstable fracture requiring absolute rest and immobilisation, pregnancy or active oncological procedures. - Suffering from some type of cognitive, psychiatric or neurological alteration that does not allow to understand the project.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
change of habits
change of habits
Other:
change of habits + auto abdominal massage
change of habits + auto abdominal massage

Locations

Country Name City State
Spain Cristina Segura Bayona Igualada Barcelona

Sponsors (2)

Lead Sponsor Collaborator
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina Universitat de Vic

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Degree of constipation Degree of constipation with Rome IV Criteria Day 0, Month 3, Month 6
Primary Stool characteristics Stool characteristics with the Bristol Scale Day 0, Month 3, Month 6
Primary Quality of life focused on patients with constipation Quality of life focused on patients with constipation with the CVE-20 questionnaire from an emotional, physical and social viewpoint. Day 0, Month 3, Month 6
Primary The number of laxatives taken by each participant The number of laxatives taken by each participant with an accounting schedule. Month 3, Month 6
Secondary Other patient characteristics such as sex, age, previous conditions, and level of physical activity with the VREM questionnaire. Day 0, Month 3, Month 6
See also
  Status Clinical Trial Phase
Completed NCT05129618 - Tolerability Study of Panosyl Isomaltooligosaccharides (PIMO), in Subjects With Chronic Idiopathic Constipation (CIC) N/A
Suspended NCT04306939 - Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study
Completed NCT06082622 - Evaluation of the Triple Management Program in the Management of Functional Chronic Constipation in Children N/A
Recruiting NCT04148248 - A Pilot Study to Explore the Role of Gut Flora in Chronic Constipation
Not yet recruiting NCT05923723 - Efficacy of a Dietary Intervention for the Treatment of Constipation in Institutionalized Older Adults. Medellín, 2022-2023. N/A
Completed NCT05036369 - Vibrant Capsule vs. Placebo for Patient Suffering From Constipation N/A
Not yet recruiting NCT06413368 - Maralixibat in Patients With Cystic Fibrosis and Constipation, A Within-Subjects Pilot Study Phase 2/Phase 3
Completed NCT04262752 - MOWOOT Device to Treat Constipation in Adults N/A
Not yet recruiting NCT04666155 - MOWOOT Device Treatment for Adults With Chronic Constipation N/A
Not yet recruiting NCT06349031 - Comparison of Efficacy & Tolerability Of PEG 4000 Versus PEG 3350+ Electrolytes for Pediatric Fecal Disimpaction Phase 4